Skip to content

Bostjan Markelc

  • PhD
  • PostDoc
  • Gray Institute for Radiation Oncology and Biology, University of Oxford
  • 13h-indexImpact measure calculated using publication and citation counts. Updated daily.
  • 364CitationsNumber of citations received by Bostjan's publications. Updated daily.

Other IDs

Groups

Co-authors (81)

  • Monika Savarin

Publications (5)

  • Increased permeability of blood vessels after reversible electroporation is facilitated by alterations in endothelial cell-to-cell junctions

    • Markelc B
    • Bellard E
    • Sersa G
    • et al.
    N/AReaders
    0Citations
    Get full text
  • Increased permeability of blood vessels after reversible electroporation is facilitated by alterations in endothelial cell-to-cell junctions

    • Markelc B
    • Bellard E
    • Sersa G
    • et al.
    N/AReaders
    N/ACitations
    Get full text
  • STING-Dependent Interferon-λ1 Induction in HT29 Cells, a Human Colorectal Cancer Cell Line, After Gamma-Radiation

    • Chen J
    • Markelc B
    • Kaeppler J
    • et al.
    N/AReaders
    0Citations
    Get full text
  • Blood flow modifying and vascular-disrupting effects of electroporation and electrochemotherapy

    • Serša G
    • Cemažar M
    • Markelc B
    N/AReaders
    0Citations
    Get full text
  • Effects of reversible and irreversible electroporation on endothelial cells and tissue blood flow

    • Markelc B
    • Cemažar M
    • Serša G
    N/AReaders
    0Citations
    Get full text

Professional experience

PostDoc

Gray Institute for Radiation Oncology and Biology, University of Oxford

April 2014 - Present

PostDoc

IPBS/CNRS UMR5089, University of Toulouse, FRANCE

April 2013 - March 2014(a year)

PhD student

Institute of Oncology Ljubljana

October 2009 - March 2013(3 years)